Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement

Introduction: This post hoc analysis of the "Early MAXimization of bronchodilation for improving COPD stability" (EMAX) trial investigated whether patients achieving early clinically important improvement (CII) sustained longer-term improvements and lower risk of clinically important deter...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of chronic obstructive pulmonary disease 2021-01, Vol.16, p.1215-1226
Hauptverfasser:	Vogelmeier, Claus F., Naya, Ian P., Maltais, Francois, Bjermer, Leif, Kerwin, Edward M., Tombs, Lee, Jones, Paul W., Compton, Chris, Lipson, David A., Boucot, Isabelle H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis bronchodilator Bronchodilator Agents - therapeutic use Chronic obstructive pulmonary disease clinically important deterioration clinically important improvement copd symptoms Drug therapy Dyspnea early improvement Forced Expiratory Volume Generalized linear models Humans Inhalers Life Sciences & Biomedicine Lung diseases, Obstructive Medical research Medicine, Experimental Original Research patient-reported outcomes Patients Pharmaceutical industry Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - drug therapy Respiratory agents Respiratory System Salmeterol Xinafoate - therapeutic use Science & Technology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!